Optimal TR-band weaning strategy while minimizing vascular access site complications.
Shah S, Gindi R, Basir MB, Khandelwal A, Alqarqaz M, Zaidan M, Voeltz M, Koenig G, Kim HE, O'Neill WW, Alaswad K.
Shah S, et al. Among authors: zaidan m.
Cardiovasc Revasc Med. 2019 Feb;20(2):133-136. doi: 10.1016/j.carrev.2018.04.013. Epub 2018 Apr 14.
Cardiovasc Revasc Med. 2019.
PMID: 29898868
Clinical Trial.